J. Ríos

Utility of urothelial mRNA markers in blood for staging and monitoring bladder cancer.

E. Ars, A. Alcaraz, M. Ribal, 2012, Urology.

SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (HR+ with or without letrozole) in trastuzumab‐pretreated, postmenopausal patients with HER2‐positive metastatic breast cancer.

A. Prat, P. Villagrasa, J. Cortés, 2018 .

Monthly changes in serum levels of S100B protein as a predictor of metastasis development in high‐risk melanoma patients

J. Malvehy, S. Puig, R. Molina, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

Differential expression of neurogenes among breast cancer subtypes identifies high risk patients

M. Mancino, V. Almendro, P. Bragado, 2015, Oncotarget.

Single reading with computer-aided detection performed by selected radiologists in a breast cancer screening program.

Xavier Bargalló, Martín Velasco, Pedro Arguis, 2014, European journal of radiology.

321TiPSOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (with or without letrozole in ER+) in previously trastuzumab-pretreated, postmenopausal patients with HER2-positive metastatic breast cancer

A. Prat, S. Morales, M. V. Oliveira, 2017 .

301 MOLECULAR MRNA MARKERS TO DETECT AND MONITOR CIRCULATING TUMOUR CELLS IN PERIPHERAL BLOD FROM UROTHELIAL CARCINOMA PATIENTS

M. Burset, E. Ars, A. Alcaraz, 2009 .

Differential expression of neurogenes among breast cancer subtypes identifies high risk patients

M. Mancino, V. Almendro, P. Bragado, 2015, Oncotarget.